unfair contract
Scope
Date
~
-
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
Economy
Korea posts worst economic contraction since 1998; down 1%
South Korea’s economic growth rate dropped by 1 percent last year, its worst performance since the 1998 Asian financial crisis when the coun...
Jan 26, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
SK in talks to buy French biologics contract manufacturer
SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...
Dec 17, 2020 (Gmt+09:00)
language -
Bio
Samsung aims to be No. 1 bio contract development, research firm
Samsung Biologics Co. has become the world’s No. 1 contract manufacturing organization (CMO) this year and aims to also lead both the contract d...
Oct 30, 2020 (Gmt+09:00)
-
South Korea GDP
Korean exports remain sluggish in Q2 as GDP sees worst contraction since 2008
South Korea's real gross domestic product contracted 3.2% quarter on quarter, posting 448.2 trillion won ($378.1 billion) in Q2, according t...
Sep 01, 2020 (Gmt+09:00)
-
Central bank
Bank of Korea sees 2020 GDP contract 1.3%; keeps base rate on hold
The Bank of Korea revised down its 2020 growth forecast for the South Korean economy to a negative 1.3% from the previous 0.2% contraction on August 2...
Aug 27, 2020 (Gmt+09:00)
-
KIC may cancel $50 mn contract with Elliott over US fund’s disputes with Korean govt
Korea Investment Corporation (KIC) is looking into whether Elliott Management’s recent move against the South Korean government constitutes a conflict...
May 17, 2018 (Gmt+09:00)